Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangi...
Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
About this item
Full title
Author / Creator
Publisher
American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are composed of R(+) and S(–) enantiomers: the R(+) enantiomer is largely devoid of beta blocker activity. We investigated the effect of R(+) enantiomers of propranolol and atenolol on the formation of IH-like blood vessels from hemangioma stem cells (HemSCs) in...
Alternative Titles
Full title
Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5e6caa76ca894a93a267f1f0dc061b4f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5e6caa76ca894a93a267f1f0dc061b4f
Other Identifiers
E-ISSN
1558-8238
